BeiGene, Ltd.

Healthcare · Biotechnology

356.00$ -0.8% vs. previous close Closing price · As of: Aug 13, 2026

Statements

Balance Sheet

BeiGene, Ltd. (ONC) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 8,189 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size %

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet ONC
Line item	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Total Assets	54	117	406	1,046	2,250	1,612	5,601	8,536	6,379	5,805	5,921	8,189
Current Assets	47	106	374	913	1,944	1,173	4,961	7,614	5,207	4,203	3,992	6,234
Cash	14	18	88	240	713	618	1,382	4,376	3,870	3,172	2,627	4,548
Cash & Short-Term Investments	44	100	368	838	1,781	983	4,651	6,618	4,535	3,172	2,627	4,548
Receivables	–	–	–	29	50	71	60	500	199	396	709	887
Inventory	–	–	–	11	16	29	89	243	282	416	495	608
Goodwill	–	–	–	0.1	0.1	0.1	0.1	0.1	0.1	–	–	–
Intangible Assets	–	–	–	20	52	5.8	54	103	95	109	130	63
Total Liabilities	28	42	53	362	496	634	1,732	2,403	1,996	2,268	2,589	3,827
Current Liabilities	13	35	35	150	246	310	1,075	1,600	1,469	1,810	2,215	1,829
Short-Term Debt	0.3	15	–	9.2	8.7	11	349	449	353	710	869	135
Accounts Payable	2.8	9.0	12	70	113	122	232	262	295	315	405	479
Long-Term Debt	–	–	–	–	–	–	184	202	209	198	166	962
Shareholders' Equity	26	-102	353	684	1,754	962	3,869	6,133	4,383	3,537	3,332	4,361
Retained Earnings	-61	-118	-237	-331	-1,007	-1,956	-3,553	-5,077	-7,080	-7,962	-8,607	-8,320
Shares Outstanding	53	32	31	42	55	60	83	93	103	104	105	113

Data as of: August 13, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Balance Sheet

Cookie settings